Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells

Mechanisms underlying interactions between a novel, clinically relevant circularized tumor necrosis factor‐related apoptosis inducing ligand (TRAIL) agonist, circularly permuted TRAIL (CPT) have been examined in multiple myeloma (MM) cells sensitive or resistant to bortezomib (BTZ). Various MM cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Yun, Hu, Xiaoyan, Li, Lin, Nkwocha, Jewel, Satta, Toshihisa, Sharma, Kanika, Kmeiciak, Maciej, Zhou, Huixing, Zhang, Zhiyao, Zhou, Liang, Chen, Wenming, Grant, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084357/
https://www.ncbi.nlm.nih.gov/pubmed/35789025
http://dx.doi.org/10.1002/hon.3045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084357/
https://www.ncbi.nlm.nih.gov/pubmed/35789025
http://dx.doi.org/10.1002/hon.3045

Ejemplares similares